The World Health Organization has undertaken actions that will promote better access to biosimilar insulins and medical devices for diabetes care. A year ago, WHO published a report, Keeping the 100-year-old promise: making insulin access universal. The report outlines how, despite the wishes of the discoverers of insulin, access to insulin and associated devices, still remains limited in many countries today. The report outlines the many barriers to access and proposes actions to address them.
Those actions include improving the availability of human insulin and insulin analogues, especially biosimilar products; enhancing the affordability of human insulin and insulin analogues; addressing access problems associated with devices to support the appropriate use of insulins; building capacity and investing in infrastructure to support access to insulins; and supporting R&D.
